Lobbying Filing Details

Total Spending

$840,000

Activities

4

Lobbyists

6

Gov't Entities

20

Filing Information
Filing UUID:
db13622d-fa0c-47fc-9ca9-74ed082026f3
Type:
Q1 - 1st Quarter - Report
Period:
2026 - 1st Quarter (Jan 1 - Mar 31)
Date Posted:
April 20, 2026 at 10:54 PM
Income:
$0
Expenses:
$840,000
Expense Method:
A
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Beth Anne Cole
Registrant
ASSOCIATION FOR ACCESSIBLE MEDICINES

Association representing the interests of the generic pharmaceutical industry.

Washington, District of Columbia
Client
ASSOCIATION FOR ACCESSIBLE MEDICINES
District of Columbia, United States of America
Lobbying Activities (4)
Activity 1
Copyright/Patent/Trademark

H.R.3160/S.1553: Promoting and Respecting Economically Vital American Innovation Leadership (PREVAIL) Act. H.R.3152/S.1546: Patent Eligibility Restoration Act of 2025. H.R.3269/S.2276: Eliminating Thickets to Increase Competition (ETHIC) Act. S.2658: Medication Affordability and Patent Integrity Act. S.1041: Affordable Prescriptions for Patients Act. S.1096: Preserve Access to Affordable Generics and Biosimilars Act. H.R.6485/S.43: Skinny Labels, Big Savings Act. H.R.4570/S.1097: Interagency Patent Coordination and Improvement Act of 2025. PTO rulemaking on inter partes review. H.R.5811: Restoring Americas Leadership in Innovation Act of 2025 (RALIA Act).

Lobbyists (5)
  • KARIN HESSLER
  • PETER KELBEL
  • ILHAAM JAFFER
  • JOHN MURPHY
  • MARK RATNER
Government Entities (7)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • White House Office
  • Health & Human Services, Dept of (HHS)
  • Patent & Trademark Office (PTO)
  • ... and 2 more
Activity 2
Medicare/Medicaid

Medicare Part D Reform. Medicaid Rebate Penalty. Medicare/Medicaid Inflation Penalties. Medicare Conditions of Participation. CMS RFC on Domestic Manufacturing. PBM Bid Transparency.

Lobbyists (6)
  • KARIN HESSLER
  • PETER KELBEL
  • ILHAAM JAFFER
  • JOHN MURPHY
  • MARK RATNER
  • ALEX KEETON
Government Entities (3)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • Centers For Medicare and Medicaid Services (CMS)
Activity 3
Pharmacy

Prescription Drug Costs. H.R.1843: To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications. S.1302: Increasing Transparency in Generic Drug Applications Act. Generic Drug Reporting Requirement Language in Public Law No. 119-60: National Defense Authorization Act for Fiscal Year 2026. Public Law No. 119-60: National Defense Authorization Act for Fiscal Year 2026. H.R.1396/S.1891: Producing Incentives for Long-term Production of Lifesaving Supply of Medicine (PILLS) Act. Drug Shortages. H.R.5526/S.1954: Biosimilar Red Tape Elimination Act (BRTEA). American Relief Act, 2025 (PL. No: 118-158) as it relates to Patent Thickets and Q1/Q2. H.R.3955/S.2062: RAPID Reserve Act. H.R.4132/S.2027: Prescription Information Modernization Act of 2025. S.1414/H.R.__: Expedited Access to Biosimilars Act. S.3469: BIOSECURE Act of 2025. Quotas on Controlled Substances. Hassan Purple Book Proposal. S.3788: Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings (CLEAR LABELS) Act. PBM Bid Transparency. H.R.7148 - Consolidated Appropriations Act, 2026 as it relates to PBM reforms and Q1/Q2.

Lobbyists (6)
  • KARIN HESSLER
  • PETER KELBEL
  • ILHAAM JAFFER
  • JOHN MURPHY
  • MARK RATNER
  • ALEX KEETON
Government Entities (2)
  • SENATE
  • HOUSE OF REPRESENTATIVES
Activity 4
Trade (domestic/foreign)

General Trade Issues. Drug Supply Chain. Rules of Origin. Country of Origin Labeling. Tariffs on Generic Medicines. Quotas on Generic Medicines. Increasing Domestic Production of Generics and Biosimilars. India Trade Negotiations. United States-Mexico-Canada Agreement. S.3788: Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings (CLEAR LABELS) Act.

Lobbyists (5)
  • KARIN HESSLER
  • PETER KELBEL
  • ILHAAM JAFFER
  • JOHN MURPHY
  • MARK RATNER
Government Entities (8)
  • SENATE
  • HOUSE OF REPRESENTATIVES
  • U.S. Trade Representative (USTR)
  • Commerce, Dept of (DOC)
  • Health & Human Services, Dept of (HHS)
  • ... and 3 more

Source: LDA.gov, data retrieved November 4, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.